Please use this identifier to cite or link to this item: http://archive.cmb.ac.lk:8080/xmlui/handle/70130/448
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRajapakse, S.-
dc.contributor.authorAbeynaike, L.-
dc.contributor.authorWickramarathne, T.-
dc.date.accessioned2011-11-21T10:43:31Z-
dc.date.available2011-11-21T10:43:31Z-
dc.date.issued2010-
dc.identifier.citation. J Clin Psychopharmacol. 2010 Oct;30(5):620-2en_US
dc.identifier.urihttp://archive.cmb.ac.lk:8080/xmlui/handle/70130/448-
dc.description.abstractA 43-year-old male patient with idiopathic Parkinson disease, on dopaminergic therapy, was admitted with confusion and agitation, diaphoresis, and hyperkinesia after the commencement of the serotonin-noradrenaline reuptake inhibitor venlafaxine 2 weeks prior for depression. He was found to have severe rhabdomyolysis and developed acute renal failure. The most likely diagnosis was serotonin syndrome induced by venlafaxine, although neuroleptic malignant syndrome was also considered. The differential diagnosis, atypical features in this presentation, and possible mechanisms are discussed.en_US
dc.language.isoenen_US
dc.titleVenlafaxine-associated serotonin syndrome causing severe rhabdomyolysis and acute renal failure in a patient with idiopathic Parkinson diseaseen_US
dc.typeJournal abstracten_US
Appears in Collections:Department of Clinical Medicine

Files in This Item:
File Description SizeFormat 
abs.txt622 BTextView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.